Menu
Currency
Research Publication

Clinical genetic variation across Hispanic populations in the Mexican Biobank.

Barberena-Jonas Carmina, C Medina-Muñoz, Santiago G SG et al.

41566040 PubMed ID
58 Authors
2026-02-21 Published
3 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BC
Barberena-Jonas Carmina
CM
C Medina-Muñoz
SG
Santiago G SG
CV
Cedillo-Castelán Viankail
VS
V Sepúlveda-Morales
TT
Tania T
GC
Gonzaga-Jáuregui Claudia
CG
C García-García
LL
Lourdes L
IA
Ioannidis Alexander G
AM
AG Moreno-Estrada
AA
Andrés A
AC
Aguilar-Salinas Carlos
CB
C Barberena-Jonas
CC
Carmina C
CS
Canizales-Quintero Sergio
SC
S Cruz-Hervert
LP
Luis Pablo LP
DG
Delgado-Sánchez Guadalupe
GF
G Ferreira-Guerrero
EE
Elizabeth E
FL
Ferreyra-Reyes Leticia
LG
L Gutiérrez-López
CC
Cecilia C
HJ
Hernández-Avila Juan Eugenio
JH
JE Huerta-Chagoya
AA
Alicia A
JL
Juárez-Figueroa Luis
LK
L Kuri-Morales
PP
Pablo P
LE
Lazcano-Ponce Eduardo
EM
E Magis-Rodríguez
CC
Carlos C
MN
Mongua-Rodríguez Norma
NM
N Moreno-Macías
HH
Hortensia H
OM
Ortega-Estrada María de Jesús
MP
MJ Palma-Martínez
MJ
María José MJ
QC
Quinto-Cortés Consuelo Dayzú
CR
CD Rodríguez-Guillén
RR
Rosario R
OM
Ordóñez-Sánchez María Luisa
MS
ML Sarti-Gutiérrez
EE
Elsa E
SK
Sandoval Karla
KS
K Sepúlveda-Amor
JJ
Jaime J
SM
Sohail Mashaal
MT
M Tapia-Conyer
RR
Roberto R
TM
Tusié-Luna María Teresa
MV
MT Valdespino-Gómez
JL
José Luis JL
TN
Téllez-Vázquez Norma
NV
N Velázquez-Monroy
OO
Oscar O
VM
Velázquez-Meza Manuel
Chapter II

Abstract

Summary of the research findings

Genetic testing for specific alleles is often recommended based on an individual's ancestry. However, the frequency of pathogenic and pharmacogenomic alleles across different Hispanic groups has not been well characterized, and existing guidelines often fail to recognize the geographic and ancestral diversity within these populations. Here analyzing data from 6,011 individuals from the nationwide Mexican Biobank, we show that Mexican individuals have striking regional differences in biomedically relevant allele frequencies, shaped both by their overall admixture proportions, but also by the local Indigenous ancestral groups contributing to their genome (for example, Nahua in central Mexico, Zapotec in the South or Maya in the Yucatan peninsula). We found ancestry-specific patterns with clinical implications that could not have been detected without a local ancestry-informed approach, including variants affecting fentanyl (rs2242480) and statin (rs4149056) metabolism, examples particularly relevant to the epidemiology of Hispanic populations. This analysis framework could inform genetic testing guidelines across the Americas. We are making available the results for 42,769 biomedically relevant genotyped variants through MexVar, a user-friendly platform designed to improve access to genomic data for the scientific community and support genetic analyses for populations of Mexican descent worldwide.

Chapter III

Analysis

Comprehensive review of ancestry and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Summary

Key Findings

Ancestry Insights

Traits Analysis

Historical Context

Scientific Assessment